Introduction {#section4-1179573519838277}
============

It is a well-known sight: empty laughing gas whippets laying on the streets, on playing grounds, and on parking places.^[@bibr1-1179573519838277]^ The use of laughing gas, also known as nitrous oxide (N~2~O), is emerging and the gas is easily available; however, users are not aware of its adverse effects following large dose or long-term use of N~2~O.^[@bibr2-1179573519838277]^ To intensify the public debate on this manner, and to demonstrate the variety of symptoms one may encounter,^[@bibr3-1179573519838277]^ we present a patient with combined spinal cord degeneration as a result of frequent laughing gas use. In addition, we provide an overview of the cases recently discussed, to illustrate that the diagnosis and treatment of neurological effects of laughing gas use are not yet coherent. Furthermore, we demonstrate that laughing gas--induced combined spinal cord degeneration can be diagnosed using both magnetic resonance imaging (MRI) and laboratory findings.

Pathophysiology {#section5-1179573519838277}
===============

Laughing gas reacts with cobalamin (vitamin B~12~) and oxidizes the cobalt ion, making the entire vitamin B~12~-complex inactive.^[@bibr3-1179573519838277]^ Vitamin B~12~ is a cofactor of methionine synthase, which converts homocysteine to methionine ([Figure 1](#fig1-1179573519838277){ref-type="fig"}). Inadequate conversion to methionine generates insufficient S-adenosyl methionine, which is required for myelin production and maintenance. Eventually, this will lead to demyelination, especially in the dorsal column of the spinal cord. Because of this, combined spinal cord degeneration will arise: not only the corticospinal tract but also the posterior funiculus is affected, thus clarifying the sensitive and motoric deficits.^[@bibr4-1179573519838277]^

![The role of vitamin B~12~ and laughing gas in the homocysteine/methionine pathway.^[@bibr4-1179573519838277]^](10.1177_1179573519838277-fig1){#fig1-1179573519838277}

Case {#section6-1179573519838277}
====

Patient A, a 30-year-old-woman, was presented to our Neurology Department with loss of power and sensory disorders in both arms and legs. The patient suffered from signs of asthma and regularly abused alcohol, however, she never experienced sensory disorders before. Her symptoms have begun 9 days ago and started with tingling sensations from the abdomen to the toes. Five days later, she had coordination problems in both hands, combined with tingling sensations continuing to her neck. She also showed Lhermitte sign while flexing her neck.

Physical examination showed a well-oriented, moderately cared woman in a wheelchair, from which she could stand up only with the help of others. The cranial nerves were intact, power in both her arms was normal, but power in both her legs was Medical Research Council (MRC) scale 4 out of 5.

Gnostic sensitivity was reduced in both arms and legs, with the right side being more affected than the left side. Vibration sensitivity was absent in both her legs. Her reflexes on the arms and legs were symmetrically elevated, and plantar reflexes were according to Babinski on both sides. Her movements were atactic and unstable.

The patient was recently institutionalized for alcohol abuse and was smoking a pack of cigarettes a day. She admitted using 50 laughing gas whippets a day for the last 2 months. Unfortunately, the patient has not given her motive considering the use of this amount of laughing gas whippets. She was hospitalized and received further treatment at the Neurology Department.

Given her clinical state, our patient had both deficits in her corticospinal tract and the posterior funiculus on both sides, mostly localized in the cervical part of the spinal cord. A cervicothoracic MRI was performed, which showed a hyperintensity in the cervical spinal cord on T2-weighted pictures ([Figure 2A](#fig2-1179573519838277){ref-type="fig"} and [B](#fig2-1179573519838277){ref-type="fig"}). These anomalies, combined with the frequent use of laughing gas, indicated a vitamin B~12~ deficiency--induced myelopathy. Laboratory findings showed a low serum vitamin B~12~, alongside both raised homocysteine and methylmalonic acid values, demonstrating the symptomatic vitamin B~12~ deficiency ([Table 1](#table1-1179573519838277){ref-type="table"}).

![(A) T2-weighted sagittal image of the cervical spinal cord. From C2 to C7, a hyperintensity is shown. (B) T2-weighted axial image of cervical spinal cord. An "inverted V-sign" is shown.](10.1177_1179573519838277-fig2){#fig2-1179573519838277}

###### 

Laboratory findings.

![](10.1177_1179573519838277-table1)

                               Reference
  --------------------- ------ -----------------
  Hemoglobin            8.3    7.0-9.3 mmol/L
  Hematocrit            0.40   0.32-0.44 L/L
  MCV                   96     82-98 fL
  Vitamin B~12~         116    140-490 pmol/L
  Folic acid            14.8   8.8-60.8 nmol/L
  Homocysteine          48.3   \<11.4 μmol/L
  Methyl malonic acid   1.43   0.0-0.35 μmol/L

Abbreviation: MCV, mean corpuscular volume.

The diagnosis of laughing gas--induced combined spinal cord degeneration was evident by these findings; intramuscular injections with 1000 µg vitamin B~12~ twice per week were started. The laughing gas use was discussed with the patient, alongside the necessity to stop at once.

During hospitalization, her symptoms were gradually improving, but her walking was still quite atactic. After 4 weeks, she was referred to medical rehabilitation; after 1 month, she was fully recovered.

Discussion {#section7-1179573519838277}
==========

A systematic search for comparable cases was conducted in PubMed, to identify the variety of symptoms and treatments. Keywords in the search were vitamin B~12~, combined spinal cord degeneration, laughing gas, and their synonyms. In total, 75 articles were identified, from which 48 were excluded after reading titles. Then, 8 articles were excluded based on their abstract. Furthermore, only the case reports were included: a total of 12 cases ([Table 2](#table2-1179573519838277){ref-type="table"}).

###### 

Laughing gas--induced myelopathy, case studies.

![](10.1177_1179573519838277-table2)

  Reference                                         Gender, age   Neurologic examination                                       MRI                                                       Treatment: intramuscular hydroxocobalamin injections
  ------------------------------------------------- ------------- ------------------------------------------------------------ --------------------------------------------------------- --------------------------------------------------------------------------
  Massey et al^[@bibr4-1179573519838277]^           Male, 36      Posterior funiculus disorder; corticospinal tract disorder   T2 hyperintensity C1-T11                                  6× 1000 μg/day for 2 weeks, then 1000 μg/week + physiotherapy
  Hsu et al^[@bibr5-1179573519838277]^              Male, 19      Posterior funiculus disorder; corticospinal tract disorder   T2 hyperintensity cervical in dorsal and lateral column   1000 μg/day for 5 days, then 2 months 1000 μg/week
  Yuan et al^[@bibr6-1179573519838277]^             Female, 20    Posterior funiculus disorder; corticospinal tract disorder   T2 hyperintensity C1-Th12, inverted V-sign                1000 μg/day for 3 months
  Chen et al^[@bibr7-1179573519838277]^             Female, 20    Posterior funiculus disorder; corticospinal tract disorder   T2 hyperintensity C1-C6 dorsal column                     2000 μg/day first 3 days, then orally
  Mancke et al^[@bibr8-1179573519838277]^           Male, 35      Posterior funiculus disorder; corticospinal tract disorder   T2 hyperintensity posterior column, inverted V-sign       1000 μg/day + methionine for 7 days, then orally 400 μg/day for 6 months
  Morris et al^[@bibr9-1179573519838277]^           Male, 22      Posterior funiculus disorder; corticospinal tract disorder   No lesions                                                1000 μg for 7 days, afterwards 1000 μg/week orally + multivitamins daily
  Thompson et al^[@bibr10-1179573519838277]^ (3×)   Male, 22      Posterior funiculus disorder; corticospinal tract disorder   No lesions                                                IVIG 0.4 g/kg/day for 5 days, then 1000 μg/day
                                                    Male, 27      Posterior funiculus disorder; corticospinal tract disorder   Not conducted                                             IVIG 0.4 g/kg/day for 5 days, then 1000 μg/day
                                                    Female, 23    Posterior funiculus disorder                                 Not conducted                                             1000 μg
  Rheinboldt et al^[@bibr11-1179573519838277]^      Male, 35      Posterior funiculus disorder; corticospinal tract disorder   T2 hyperintensity C2-C3 and C6-C7                         One injection of 1000 μg; supportive care
  Cheng et al^[@bibr12-1179573519838277]^           Female, 22    Posterior funiculus disorder; corticospinal tract disorder   T2 hyperintensity dorsal column C2-C4                     1000 μg/day + physiotherapy
  Wijesekera et al^[@bibr13-1179573519838277]^      Female, 19    Posterior funiculus disorder; corticospinal tract disorder   T2 hyperintensity central and dorsal column C2-Th11       6× 1000 μg injections, then symptomatic therapy
  Singer et al^[@bibr14-1179573519838277]^          Female, 27    Posterior funiculus disorder; corticospinal tract disorder   T2 hyperintensity dorsal cervical column                  Monthly 1000μ μg injections for 10 months
  Butzkueven et al^[@bibr15-1179573519838277]^      Male, 23      Posterior funiculus disorder; corticospinal tract disorder   T2 hyperintensity dorsal cervical column                  1000 μg/day and methionine orally 1 g/day for 3 months

Abbreviations: IVIG, intravenous immunoglobulin; MRI, magnetic resonance imaging.

Diagnostics {#section8-1179573519838277}
-----------

The underlying principle of diagnosing laughing gas--induced myelopathy is knowing the nitrous oxide drug use and history of the patient. A subacute start of sensory and motoric symptoms combined with laughing gas use calls for an extensive neurological examination.^[@bibr10-1179573519838277]^

Most case studies report a loss of proprioception in the lower extremities as the most important finding indicating dorsal column pathology.^[@bibr5-1179573519838277][@bibr6-1179573519838277]--[@bibr7-1179573519838277],[@bibr9-1179573519838277],[@bibr10-1179573519838277],[@bibr12-1179573519838277][@bibr13-1179573519838277][@bibr14-1179573519838277]--[@bibr15-1179573519838277]^ Ataxia is also found frequently; falling and being unable to walk are extreme symptoms of loss of proprioception.^[@bibr9-1179573519838277]^ Lost coordination and a positive Romberg are found frequently.^[@bibr5-1179573519838277][@bibr6-1179573519838277]--[@bibr7-1179573519838277],[@bibr9-1179573519838277],[@bibr12-1179573519838277],[@bibr15-1179573519838277]^ Further sensory examination can point out diminished vibration and touch senses, mostly bilateral.

Lateral dorsal pathology is characterized by hyperreflexia in upper or isolated in the lower extremities; one case has described finding a clonus.^[@bibr8-1179573519838277]^ Muscle weakness and fine motoric abilities may decline; even a positive bilateral Babinski can be found.^[@bibr6-1179573519838277],[@bibr11-1179573519838277]^

Active or passive bending of the neck can indicate a positive Lhermitte sign.^[@bibr5-1179573519838277],[@bibr9-1179573519838277],[@bibr10-1179573519838277],[@bibr12-1179573519838277]^

Through laboratory research, a functional vitamin B~12~ deficiency can be demonstrated. Complete blood count will mostly show a macrocytic anemia; however, abundant folic acid consumed through diet will not result in the absence of megaloblasts in the blood count.^[@bibr16-1179573519838277]^ Low count of vitamin B~12~ can be the next step, but symptoms are not always accompanied by decreased values,^[@bibr6-1179573519838277],[@bibr10-1179573519838277],[@bibr11-1179573519838277],[@bibr14-1179573519838277]^ for instance after vitamin B~12~ supplementation.^[@bibr7-1179573519838277]^

To be certain that vitamin B~12~ is pathologically deficient, both homocysteine and methylmalonic acid must be measured. Vitamin B~12~ is a cofactor of both,^[@bibr17-1179573519838277]^ so a functional shortage can result in raised homocysteine and methylmalonic acid values.^[@bibr4-1179573519838277],[@bibr8-1179573519838277][@bibr9-1179573519838277]--[@bibr10-1179573519838277],[@bibr12-1179573519838277],[@bibr14-1179573519838277]^

Magnetic resonance imaging can demonstrate hyperintensity in the dorsal and lateral columns of the spinal cord. However, MRI is not always conducted, or no lesions can be seen.^[@bibr9-1179573519838277],[@bibr10-1179573519838277]^ It can give an important insight on the diagnosis: symptoms depended on the location of the lesions. Hyperintensity can cover the entire cervical spinal cord.^[@bibr6-1179573519838277],[@bibr13-1179573519838277]^ The axial images can show an "inverted V-sign" at the height of the lesion ([Figure 2B](#fig2-1179573519838277){ref-type="fig"})^[@bibr6-1179573519838277],[@bibr8-1179573519838277],[@bibr18-1179573519838277]^: this demonstrates the involvement of both dorsal and lateral columns of the cervical spinal cord.

Treatment {#section9-1179573519838277}
---------

Abstinence of laughing gas will be the first step in treating this combined spinal cord degeneration. Alongside, vitamin B~12~ must be supplemented, as the nitrous oxide has exhausted the cobalamin stock, thus leading to the symptoms.

In the case study, no exact answer is given considering the treatment of laughing gas--induced combined spinal cord degeneration. Most patients are treated with intramuscular hydroxocobalamin injections of 1000 µg; however, both duration and interval of these injections vary greatly. Treatment of only one injection^[@bibr13-1179573519838277]^ or daily injections for a period of 2 months^[@bibr15-1179573519838277]^ are described. Also, considerable variation in frequency is described: from daily to weekly injections^[@bibr4-1179573519838277],[@bibr5-1179573519838277],[@bibr9-1179573519838277]^ or monthly injections of hydroxocobalamin are provided.^[@bibr14-1179573519838277]^

Besides these variations, it is not clearly described whether supportive therapy must be provided, such as physiotherapy,^[@bibr4-1179573519838277],[@bibr13-1179573519838277][@bibr14-1179573519838277]--[@bibr15-1179573519838277]^ or whether methionine must be supplemented next to cobalamin.^[@bibr8-1179573519838277],[@bibr15-1179573519838277]^

The National Health Care Institute advises weekly intramuscular injections for a longer period of time (2 years) when severe neurological symptoms are present.^[@bibr19-1179573519838277]^

Conclusions {#section10-1179573519838277}
===========

As presented in our case, it is essential to know about the use of laughing gas when a patient is presented with subacute spinal cord degeneration. This can be the first step in diagnosing laughing gas--induced myelopathy, which is straightforward to treat by supplementing vitamin B~12~. MRI is important and essential for the diagnosis.

Although no consensus is reached considering the exact treatment, more research is required regarding laughing gas--induced subacute combined spinal cord degeneration.

Attitude of society relating to the use of laughing gas is liberalizing, which can lead to more and more severe cases being presented to the ER. N~2~O may be a relatively safe drug in recreational use, but certainly not in high daily dose, when used very frequently or at very young age. Therefore, the knowledge of pathophysiology, diagnosis, and treatment is essential, and social awareness is of great interest.
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